Literatur

[1] Brigden, W. (1957): Uncommon myocardial diseases: the non-coronary cardiomyopathies, Lancet (2), Seite 1179-84.

[2] Goodwin, J. F. und Oakley, C. M. (1972): The cardiomyopathies, Br Heart J (34) [6], Seite 545-52.

[3] (1980): Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies, Br Heart J (44) [6], Seite 672-3.

[4] Richardson, P.; McKenna, W.; Bristow, M.; Maisch, B.; Mautner, B.; O'Connell, J.; Olsen, E.; Thiene, G.; Goodwin, J.; Gyarfas, I.; Martin, I. und Nordet, P. (1996): Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies, Circulation (93) [5], Seite 841-2.

[5] Felker, G. M.; Thompson, R. E.; Hare, J. M.; Hruban, R. H.; Clemetson, D. E.; Howard, D. L.; Baughman, K. L. und Kasper, E. K. (2000): Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy, N Engl J Med (342) [15], Seite 1077-84.

[6] Codd, M. B.; Sugrue, D. D.; Gersh, B. J. und Melton, L. J., 3rd (1989): Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984, Circulation (80) [3], Seite 564-72.

[7] Rakar, S.; Sinagra, G.; Di Lenarda, A.; Poletti, A.; Bussani, R.; Silvestri, F. und Camerini, F. (1997): Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group, Eur Heart J (18) [1], Seite 117-23.

[8] Komajda, M.; Jais, J. P.; Reeves, F.; Goldfarb, B.; Bouhour, J. B.; Juillieres, Y.; Lanfranchi, J.; Peycelon, P.; Geslin, P.; Carrie, D. und et al. (1990): Factors predicting mortality in idiopathic dilated cardiomyopathy, Eur Heart J (11) [9], Seite 824-31.

[9] Sugrue, D. D.; Rodeheffer, R. J.; Codd, M. B.; Ballard, D. J.; Fuster, V. und Gersh, B. J. (1992): The clinical course of idiopathic dilated cardiomyopathy. A population-based study, Ann Intern Med (117) [2], Seite 117-23.

[10] Johnson, R. A. und Palacios, I. (1982): Dilated cardiomyopathies of the adult (first of two parts), N Engl J Med (307) [17], Seite 1051-8.

[11] Aretz, H. T. (1987): Myocarditis: the Dallas criteria, Hum Pathol (18) [6], Seite 619-24.

[12] Maisch, B.; Portig, I.; Ristic, A.; Hufnagel, G. und Pankuweit, S. (2000): Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report, Herz (25) [3], Seite 200-9.

[13] Hoppe, U. C.; Bohm, M.; Dietz, R.; Hanrath, P.; Kroemer, H. K.; Osterspey, A.; Schmaltz, A. A. und Erdmann, E. (2005): Leitlinien zur Therapie der chronischen Herzinsuffizienz, Z Kardiol (94) [8], Seite 488-509.

[14] Swedberg, K.; Cleland, J.; Dargie, H.; Drexler, H.; Follath, F.; Komajda, M.; Tavazzi, L.; Smiseth, O. A.; Gavazzi, A.; Haverich, A.; Hoes, A.; Jaarsma, T.; Korewicki, J.; Levy, S.; Linde, C.; Lopez-Sendon, J. L.; Nieminen, M. S.; Pierard, L. und Remme, W. J. (2005): Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology, Eur Heart J (26) [11], Seite 1115-40. Epub 2005 May 18.

[15] Battersby, E.J. und Glenner, G.G. (1961): Familial cardiomyopathy, Am J Med (30), Seite 382-91.

[16] Schrader, W.H.; Pankey, G.A.; Davis, R.B. und Theologides, A. (1961): Familial idiopathic cardiomegaly, Circulation (24), Seite 599-606.

[17] Whitfield, A.G. (1961): Familial cardiomyopathy, Quart J Med (3), Seite 119-34.

[18] Mestroni, L.; Maisch, B.; McKenna, W. J.; Schwartz, K.; Charron, P.; Rocco, C.; Tesson, F.; Richter, A.; Wilke, A. und Komajda, M. (1999): Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy, Eur Heart J (20) [2], Seite 93-102.

[19] Michels, V. V.; Moll, P. P.; Miller, F. A.; Tajik, A. J.; Chu, J. S.; Driscoll, D. J.; Burnett, J. C.; Rodeheffer, R. J.; Chesebro, J. H. und Tazelaar, H. D. (1992): The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy, N Engl J Med (326) [2], Seite 77-82.

[20] Grünig, E.; Tasman, J. A.; Kucherer, H.; Franz, W.; Kubler, W. und Katus, H. A. (1998): Frequency and phenotypes of familial dilated cardiomyopathy, J Am Coll Cardiol (31) [1], Seite 186-94.

[21] Mestroni, L.; Rocco, C.; Gregori, D.; Sinagra, G.; Di Lenarda, A.; Miocic, S.; Vatta, M.; Pinamonti, B.; Muntoni, F.; Caforio, A. L.; McKenna, W. J.; Falaschi, A.; Giacca, M. und Camerini (1999): Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group, J Am Coll Cardiol (34) [1], Seite 181-90.

[22] Kelly, D. P. und Strauss, A. W. (1994): Inherited cardiomyopathies, N Engl J Med (330) [13], Seite 913-9.

[23] Suomalainen, A.; Paetau, A.; Leinonen, H.; Majander, A.; Peltonen, L. und Somer, H. (1992): Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA, Lancet (340) [8831], Seite 1319-20.

[24] Zeviani, M.; Servidei, S.; Gellera, C.; Bertini, E.; DiMauro, S. und DiDonato, S. (1989): An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region, Nature (339) [6222], Seite 309-11.

[25] Bowles, N. E.; Bowles, K. R. und Towbin, J. A. (2000): The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy, Herz (25) [3], Seite 168-75.

[26] Jung, M.; Poepping, I.; Perrot, A.; Ellmer, A. E.; Wienker, T. F.; Dietz, R.; Reis, A. und Osterziel, K. J. (1999): Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22, Am J Hum Genet (65) [4], Seite 1068-77.

[27] Sylvius, N.; Tesson, F.; Gayet, C.; Charron, P.; Benaiche, A.; Peuchmaurd, M.; Duboscq-Bidot, L.; Feingold, J.; Beckmann, J. S.; Bouchier, C. und Komajda, M. (2001): A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16, Am J Hum Genet (68) [1], Seite 241-6.

[28] Messina, D. N.; Speer, M. C.; Pericak-Vance, M. A. und McNally, E. M. (1997): Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23, Am J Hum Genet (61) [4], Seite 909-17.

[29] Krajinovic, M.; Pinamonti, B.; Sinagra, G.; Vatta, M.; Severini, G. M.; Milasin, J.; Falaschi, A.; Camerini, F.; Giacca, M. und Mestroni, L. (1995): Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group, Am J Hum Genet (57) [4], Seite 846-52.

[30] Bowles, K. R.; Gajarski, R.; Porter, P.; Goytia, V.; Bachinski, L.; Roberts, R.; Pignatelli, R. und Towbin, J. A. (1996): Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23, J Clin Invest (98) [6], Seite 1355-60.

[31] Osterziel, K. J. und Perrot, A. (2005): Dilated cardiomyopathy: more genes means more phenotypes, Eur Heart J (21), Seite 21

[32] Muntoni, F.; Cau, M.; Ganau, A.; Congiu, R.; Arvedi, G.; Mateddu, A.; Marrosu, M. G.; Cianchetti, C.; Realdi, G.; Cao, A. und et al. (1993): Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy, N Engl J Med (329) [13], Seite 921-5.

[33] Hoffman, E. P.; Brown, R. H., Jr. und Kunkel, L. M. (1987): Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell (51) [6], Seite 919-28.

[34] Tsubata, S.; Bowles, K. R.; Vatta, M.; Zintz, C.; Titus, J.; Muhonen, L.; Bowles, N. E. und Towbin, J. A. (2000): Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy, J Clin Invest (106) [5], Seite 655-62.

[35] Li, D.; Tapscoft, T.; Gonzalez, O.; Burch, P. E.; Quinones, M. A.; Zoghbi, W. A.; Hill, R.; Bachinski, L. L.; Mann, D. L. und Roberts, R. (1999): Desmin mutation responsible for idiopathic dilated cardiomyopathy, Circulation (100) [5], Seite 461-4.

[36] Kass, S.; MacRae, C.; Graber, H. L.; Sparks, E. A.; McNamara, D.; Boudoulas, H.; Basson, C. T.; Baker, P. B., 3rd; Cody, R. J. und andere (1994): A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1, Nat Genet (7) [4], Seite 546-51.

[37] Fatkin, D.; MacRae, C.; Sasaki, T.; Wolff, M. R.; Porcu, M.; Frenneaux, M.; Atherton, J.; Vidaillet, H. J., Jr.; Spudich, S.; De Girolami, U.; Seidman, J. G.; Seidman, C.; Muntoni, F.; Muehle, G.; Johnson, W. und McDonough, B. (1999): Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease, N Engl J Med (341) [23], Seite 1715-24.

[38] Olson, T. M.; Michels, V. V.; Thibodeau, S. N.; Tai, Y. S. und Keating, M. T. (1998): Actin mutations in dilated cardiomyopathy, a heritable form of heart failure, Science (280) [5364], Seite 750-2.

[39] Seidman, J. G. und Seidman, C. (2001): The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms, Cell (104) [4], Seite 557-67.

[40] Royal Prince Alfred Hospital Sydney, Australien:: FHC mutation database. http://www.angis.org.au/Databases/Heart/ Stand: 15. März 2005.

[41] University of Wales College of Medicine, UK:: Human Gene Mutation Database at the Institute of Medical Genetics. http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html". Stand: 15. März 2005.

[42] CardioGenomics Program for Genomic Applications Project 3 Boston, USA:: Mutation database. http://genetics.med.harvard.edu/~seidman/cg3". Stand: 15. März 2005.

[43] Satoh, M.; Takahashi, M.; Sakamoto, T.; Hiroe, M.; Marumo, F. und Kimura, A. (1999): Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene, Biochem Biophys Res Commun (262) [2], Seite 411-7.

[44] Blair, E.; Redwood, C.; Ashrafian, H.; Oliveira, M.; Broxholme, J.; Kerr, B.; Salmon, A.; Ostman-Smith, I. und Watkins, H. (2001): Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis, Hum Mol Genet (10) [11], Seite 1215-20.

[45] Geier, C.; Perrot, A.; Ozcelik, C.; Binner, P.; Counsell, D.; Hoffmann, K.; Pilz, B.; Martiniak, Y.; Gehmlich, K.; van der Ven, P. F.; Furst, D. O.; Vornwald, A.; von Hodenberg, E.; Nurnberg, P.; Scheffold, T.; Dietz, R. und Osterziel, K. J. (2003): Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy, Circulation (107) [10], Seite 1390-5.

[46] Hayashi, T.; Arimura, T.; Itoh-Satoh, M.; Ueda, K.; Hohda, S.; Inagaki, N.; Takahashi, M.; Hori, H.; Yasunami, M.; Nishi, H.; Koga, Y.; Nakamura, H.; Matsuzaki, M.; Choi, B. Y.; Bae, S. W.; You, C. W.; Han, K. H.; Park, J. E.; Knoll, R.; Hoshijima, M.; Chien, K. R. und Kimura, A. (2004): Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy, J Am Coll Cardiol (44) [11], Seite 2192-201.

[47] Thierfelder, L.; Watkins, H.; MacRae, C.; Lamas, R.; McKenna, W.; Vosberg, H. P.; Seidman, J. G. und Seidman, C. E. (1994): Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere, Cell (77) [5], Seite 701-12.

[48] Kamisago, M.; Sharma, S. D.; DePalma, S. R.; Solomon, S.; Sharma, P.; McDonough, B.; Smoot, L.; Mullen, M. P.; Woolf, P. K.; Wigle, E. D.; Seidman, J. G. und Seidman, C. E. (2000): Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy, N Engl J Med (343) [23], Seite 1688-96.

[49] Saez, L. J.; Gianola, K. M.; McNally, E. M.; Feghali, R.; Eddy, R.; Shows, T. B. und Leinwand, L. A. (1987): Human cardiac myosin heavy chain genes and their linkage in the genome, Nucleic Acids Res (15) [13], Seite 5443-59.

[50] Matsuoka, R.; Yoshida, M. C.; Kanda, N.; Kimura, M.; Ozasa, H. und Takao, A. (1989): Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13, Am J Med Genet (32) [2], Seite 279-84.

[51] Jaenicke, T.; Diederich, K. W.; Haas, W.; Schleich, J.; Lichter, P.; Pfordt, M.; Bach, A. und Vosberg, H. P. (1990): The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product, Genomics (8) [2], Seite 194-206.

[52] Geisterfer-Lowrance, A. A.; Kass, S.; Tanigawa, G.; Vosberg, H. P.; McKenna, W.; Seidman, C. E. und Seidman, J. G. (1990): A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation, Cell (62) [5], Seite 999-1006.

[53] Paré, J.A.P.; Fraser, R.G.; Pirozynski, W.J.; Shanks, J.A. und Stubington, D. (1961): Hereditary cardiovascular dysplasia: a form of familial cardiomyopathy, Am J Med (31), Seite 37-62.

[54] Richard, P.; Charron, P.; Carrier, L.; Ledeuil, C.; Cheav, T.; Pichereau, C.; Benaiche, A.; Isnard, R.; Dubourg, O.; Burban, M.; Gueffet, J. P.; Millaire, A.; Desnos, M.; Schwartz, K.; Hainque, B. und Komajda, M. (2003): Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy, Circulation (107) [17], Seite 2227-32.

[55] Bonne, G.; Carrier, L.; Richard, P.; Hainque, B. und Schwartz, K. (1998): Familial hypertrophic cardiomyopathy: from mutations to functional defects, Circ Res (83) [6], Seite 580-93.

[56] Anderson, P. A.; Greig, A.; Mark, T. M.; Malouf, N. N.; Oakeley, A. E.; Ungerleider, R. M.; Allen, P. D. und Kay, B. K. (1995): Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart, Circ Res (76) [4], Seite 681-6.

[57] Mesnard, L.; Logeart, D.; Taviaux, S.; Diriong, S.; Mercadier, J. J. und Samson, F. (1995): Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart, Circ Res (76) [4], Seite 687-92.

[58] Zot, A. S. und Potter, J. D. (1987): Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction, Annu Rev Biophys Biophys Chem (16), Seite 535-59.

[59] Townsend, P. J.; Farza, H.; MacGeoch, C.; Spurr, N. K.; Wade, R.; Gahlmann, R.; Yacoub, M. H. und Barton, P. J. (1994): Human cardiac troponin T: identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q, Genomics (21) [2], Seite 311-6.

[60] Jin, J. P.; Huang, Q. Q.; Yeh, H. I. und Lin, J. J. (1992): Complete nucleotide sequence and structural organization of rat cardiac troponin T gene. A single gene generates embryonic and adult isoforms via developmentally regulated alternative splicing, J Mol Biol (227) [4], Seite 1269-76.

[61] Forissier, J. F.; Carrier, L.; Farza, H.; Bonne, G.; Bercovici, J.; Richard, P.; Hainque, B.; Townsend, P. J.; Yacoub, M. H.; Faure, S.; Dubourg, O.; Millaire, A.; Hagege, A. A.; Desnos, M.; Komajda, M. und Schwartz, K. (1996): Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy, Circulation (94) [12], Seite 3069-73.

[62] Moolman, J. C.; Corfield, V. A.; Posen, B.; Ngumbela, K.; Seidman, C.; Brink, P. A. und Watkins, H. (1997): Sudden death due to troponin T mutations, J Am Coll Cardiol (29) [3], Seite 549-55.

[63] Watkins, H.; Conner, D.; Thierfelder, L.; Jarcho, J. A.; MacRae, C.; McKenna, W. J.; Maron, B. J.; Seidman, J. G. und Seidman, C. E. (1995): Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy, Nat Genet (11) [4], Seite 434-7.

[64] Daehmlow, S.; Erdmann, J.; Knueppel, T.; Gille, C.; Froemmel, C.; Hummel, M.; Hetzer, R. und Regitz-Zagrosek, V. (2002): Novel mutations in sarcomeric protein genes in dilated cardiomyopathy, Biochem Biophys Res Commun (298) [1], Seite 116-20.

[65] Olson, T. M.; Kishimoto, N. Y.; Whitby, F. G. und Michels, V. V. (2001): Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy, J Mol Cell Cardiol (33) [4], Seite 723-32.

[66] Kimura, A.; Harada, H.; Park, J. E.; Nishi, H.; Satoh, M.; Takahashi, M.; Hiroi, S.; Sasaoka, T.; Ohbuchi, N.; Nakamura, T.; Koyanagi, T.; Hwang, T. H.; Choo, J. A.; Chung, K. S.; Hasegawa, A.; Nagai, R.; Okazaki, O.; Nakamura, H.; Matsuzaki, M.; Sakamoto, T.; Toshima, H.; Koga, Y.; Imaizumi, T. und Sasazuki, T. (1997): Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy, Nat Genet (16) [4], Seite 379-82.

[67] Murphy, R. T.; Mogensen, J.; Shaw, A.; Kubo, T.; Hughes, S. und McKenna, W. J. (2004): Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy, Lancet (363) [9406], Seite 371-2.

[68] Hoffmann, B.; Schmidt-Traub, H.; Perrot, A.; Osterziel, K. J. und Gessner, R. (2001): First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy, Hum Mutat (17) [6], Seite 524.

[69] Mogensen, J.; Murphy, R. T.; Shaw, T.; Bahl, A.; Redwood, C.; Watkins, H.; Burke, M.; Elliott, P. M. und McKenna, W. J. (2004): Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy, J Am Coll Cardiol (44) [10], Seite 2033-40.

[70] Mogensen, J.; Klausen, I. C.; Pedersen, A. K.; Egeblad, H.; Bross, P.; Kruse, T. A.; Gregersen, N.; Hansen, P. S.; Baandrup, U. und Borglum, A. D. (1999): Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy, J Clin Invest (103) [10], Seite R39-43.

[71] Poetter, K.; Jiang, H.; Hassanzadeh, S.; Master, S. R.; Chang, A.; Dalakas, M. C.; Rayment, I.; Sellers, J. R.; Fananapazir, L. und Epstein, N. D. (1996): Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle, Nat Genet (13) [1], Seite 63-9.

[72] Gerull, B.; Gramlich, M.; Atherton, J.; McNabb, M.; Trombitas, K.; Sasse-Klaassen, S.; Seidman, J. G.; Seidman, C.; Granzier, H.; Labeit, S.; Frenneaux, M. und Thierfelder, L. (2002): Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy, Nat Genet (30) [2], Seite 201-4.

[73] Knöll, R.; Hoshijima, M.; Hoffman, H. M.; Person, V.; Lorenzen-Schmidt, I.; Bang, M. L.; Hayashi, T.; Shiga, N.; Yasukawa, H.; Schaper, W.; McKenna, W.; Yokoyama, M.; Schork, N. J.; Omens, J. H.; McCulloch, A. D.; Kimura, A.; Gregorio, C. C.; Poller, W.; Schaper, J.; Schultheiss, H. P. und Chien, K. R. (2002): The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy, Cell (111) [7], Seite 943-55.

[74] Arimura, T.; Hayashi, T.; Terada, H.; Lee, S. Y.; Zhou, Q.; Takahashi, M.; Ueda, K.; Nouchi, T.; Hohda, S.; Shibutani, M.; Hirose, M.; Chen, J.; Park, J. E.; Yasunami, M.; Hayashi, H. und Kimura, A. (2004): A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C, J Biol Chem (279) [8], Seite 6746-52.

[75] Olson, T. M.; Illenberger, S.; Kishimoto, N. Y.; Huttelmaier, S.; Keating, M. T. und Jockusch, B. M. (2002): Metavinculin mutations alter actin interaction in dilated cardiomyopathy, Circulation (105) [4], Seite 431-7.

[76] Schmitt, J. P.; Kamisago, M.; Asahi, M.; Li, G. H.; Ahmad, F.; Mende, U.; Kranias, E. G.; MacLennan, D. H.; Seidman, J. G. und Seidman, C. E. (2003): Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science (299) [5611], Seite 1410-3.

[77] Bienengraeber, M.; Olson, T. M.; Selivanov, V. A.; Kathmann, E. C.; O'Cochlain, F.; Gao, F.; Karger, A. B.; Ballew, J. D.; Hodgson, D. M.; Zingman, L. V.; Pang, Y. P.; Alekseev, A. E. und Terzic, A. (2004): ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating, Nat Genet (36) [4], Seite 382-7.

[78] Olson, T. M. und Keating, M. T. (1996): Mapping a cardiomyopathy locus to chromosome 3p22-p25, J Clin Invest (97) [2], Seite 528-32.

[79] McNair, W. P.; Ku, L.; Taylor, M. R.; Fain, P. R.; Dao, D.; Wolfel, E. und Mestroni, L. (2004): SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia, Circulation (110) [15], Seite 2163-7.

[80] Bione, S.; D'Adamo, P.; Maestrini, E.; Gedeon, A. K.; Bolhuis, P. A. und Toniolo, D. (1996): A novel X-linked gene, G4.5. is responsible for Barth syndrome, Nat Genet (12) [4], Seite 385-9.

[81] Schönberger, J.; Wang, L.; Shin, J. T.; Kim, S. D.; Depreux, F. F.; Zhu, H.; Zon, L.; Pizard, A.; Kim, J. B.; Macrae, C. A.; Mungall, A. J.; Seidman, J. G. und Seidman, C. E. (2005): Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss, Nat Genet (27), Seite 27

[82] Henry, W. L.; Gardin, J. M.; Ware, J. H.; Philips, A. V. und Cooper, T. A. (1980): Echocardiographic measurements in normal subjects from infancy to old age, Circulation (62) [5], Seite 1054-61.

[83] Miller, S. A.; Dykes, D. D. und Polesky, H. F. (1988): A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res (16) [3], Seite 1215.

[84] Mullis, K. B. und Faloona, F. A. (1987): Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction, Methods Enzymol (155), Seite 335-50.

[85] Cheng, S.; Chang, S. Y.; Gravitt, P. und Respess, R. (1994): Long PCR, Nature (369) [6482], Seite 684-5.

[86] Orita, M.; Iwahana, H.; Kanazawa, H.; Hayashi, K. und Sekiya, T. (1989): Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms, Proc Natl Acad Sci U S A (86) [8], Seite 2766-70.

[87] Spinardi, L.; Mazars, R. und Theillet, C. (1991): Protocols for an improved detection of point mutations by SSCP, Nucleic Acids Res (19) [14], Seite 4009.

[88] Condie, A.; Eeles, R.; Borresen, A. L.; Coles, C.; Cooper, C. und Prosser, J. (1993): Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques, Hum Mutat (2) [1], Seite 58-66.

[89] Glavac, D. und Dean, M. (1993): Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations, Hum Mutat (2) [5], Seite 404-14.

[90] Grompe, M. (1993): The rapid detection of unknown mutations in nucleic acids, Nat Genet (5) [2], Seite 111-7.

[91] Hayashi, K. und Yandell, D. W. (1993): How sensitive is PCR-SSCP?, Hum Mutat (2) [5], Seite 338-46.

[92] Sanger, F.; Nicklen, S. und Coulson, A. R. (1977): DNA sequencing with chain-terminating inhibitors, Proc Natl Acad Sci U S A (74) [12], Seite 5463-7.

[93] Cooper, D. N. und Schmidtke, J. (1984): DNA restriction fragment length polymorphisms and heterozygosity in the human genome, Hum Genet (66) [1], Seite 1-16.

[94] Max Heiman, Yale University New Haven, USA:: Webcutter 2.0. http://www.firstmarket.com/cutter/cut2.html

[95] Nagamine, C. M.; Chan, K. und Lau, Y. F. (1989): A PCR artifact: generation of heteroduplexes, Am J Hum Genet (45) [2], Seite 337-9.

[96] Dianzani, I.; Camaschella, C.; Ponzone, A. und Cotton, R. G. (1993): Dilemmas and progress in mutation detection, Trends Genet (9) [12], Seite 403-5.

[97] den Dunnen, J. T. und Antonarakis, S. E. (2000): Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion, Hum Mutat (15) [1], Seite 7-12.

[98] HGVS, Human Genome Variation Society:: Nomenclature for the description of sequence variations. http://www.genomic.unimelb.edu.au/mdi/mutnomen/". Stand: 4. März 2005.

[99] Erdmann, J.; Daehmlow, S.; Wischke, S.; Senyuva, M.; Werner, U.; Raible, J.; Tanis, N.; Dyachenko, S.; Hummel, M.; Hetzer, R. und Regitz-Zagrosek, V. (2003): Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy, Clin Genet (64) [4], Seite 339-49.

[100] Regitz-Zagrosek, V.; Erdmann, J.; Wellnhofer, E.; Raible, J. und Fleck, E. (2000): Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy, Circulation (102) [17], Seite E112-6.

[101] Hina, K.; Kusachi, S.; Iwasaki, K.; Nogami, K.; Moritani, H.; Kita, T.; Taniguchi, G. und Tsuji, T. (1993): Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value, Clin Cardiol (16) [5], Seite 403-7.

[102] Raible, J.; Kallisch, H.; Erdmann, J. und Regitz-Zagrosek, V. (2001): Sensitivität und Spezifität von SSCP und Temperatur-modulierter Heteroduplexanalyse (TMHA) in der Diagnostik von Mutationen im b MHC-Gen, Z Kardiol (90, Supplement 2), Seite 323.

[103] Highsmith, W. E., Jr.; Nataraj, A. J.; Jin, Q.; O'Connor, J. M.; El-Nabi, S. H.; Kusukawa, N. und Garner, M. M. (1999): Use of DNA toolbox for the characterization of mutation scanning methods. II: evaluation of single-strand conformation polymorphism analysis, Electrophoresis (20) [6], Seite 1195-203.

[104] Epstein, N. D.; Cohn, G. M.; Cyran, F. und Fananapazir, L. (1992): Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation, Circulation (86) [2], Seite 345-52.

[105] Philips, A. V. und Cooper, T. A. (2000): RNA processing and human disease, Cell Mol Life Sci (57) [2], Seite 235-49.

[106] Krawczak, M.; Reiss, J. und Cooper, D. N. (1992): The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences, Hum Genet (90) [1-2], Seite 41-54.

[107] Berkeley Drosophila Genome Project, Universitiy of California Berkeley, USA:: Splice Site Prediction. http://www.fruitfly.org/seq_tools/splice.html

[108] Grantham, R.; Gautier, C.; Gouy, M.; Mercier, R. und Pave, A. (1980): Codon catalog usage and the genome hypothesis, Nucleic Acids Res (8) [1], Seite r49-r62.

[109] Robinson, M.; Lilley, R.; Little, S.; Emtage, J. S.; Yarranton, G.; Stephens, P.; Millican, A.; Eaton, M. und Humphreys, G. (1984): Codon usage can affect efficiency of translation of genes in Escherichia coli, Nucleic Acids Res (12) [17], Seite 6663-71.

[110] Bulmer, M. (1988): Codon usage and intragenic position, J Theor Biol (133) [1], Seite 67-71.

[111] Kazusa DNA Research Institute, Japan:: Codon Usage Database. http://www.kazusa.or.jp/codon". Stand: 15. März 2005.

[112] Zatkova, A.; Messiaen, L.; Vandenbroucke, I.; Wieser, R.; Fonatsch, C.; Krainer, A. R. und Wimmer, K. (2004): Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1, Hum Mutat (24) [6], Seite 491-501.

[113] Lorson, C. L.; Hahnen, E.; Androphy, E. J. und Wirth, B. (1999): A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy, Proc Natl Acad Sci U S A (96) [11], Seite 6307-11.

[114] Shimizu, M.; Ino, H.; Yasuda, T.; Fujino, N.; Uchiyama, K.; Mabuchi, T.; Konno, T.; Kaneda, T.; Fujita, T.; Masuta, E.; Katoh, M.; Funada, A. und Mabuchi, H. (2005): Gene mutations in adult Japanese patients with dilated cardiomyopathy, Circ J (69) [2], Seite 150-3.

[115] Suzuki, M.; Carlson, K. M.; Marchuk, D. A. und Rockman, H. A. (2002): Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy, Circulation (105) [15], Seite 1824-9.

[116] Chien, K. R. (1999): Stress pathways and heart failure, Cell (98) [5], Seite 555-8.

[117] Watkins, H.; Rosenzweig, A.; Hwang, D. S.; Levi, T.; McKenna, W.; Seidman, C. E. und Seidman, J. G. (1992): Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy, N Engl J Med (326) [17], Seite 1108-14.

[118] Charron, P.; Dubourg, O.; Desnos, M.; Bennaceur, M.; Carrier, L.; Camproux, A. C.; Isnard, R.; Hagege, A.; Langlard, J. M.; Bonne, G.; Richard, P.; Hainque, B.; Bouhour, J. B.; Schwartz, K. und Komajda, M. (1998): Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene, Circulation (97) [22], Seite 2230-6.

[119] Marian, A. J. und Roberts, R. (2001): The molecular genetic basis for hypertrophic cardiomyopathy, J Mol Cell Cardiol (33) [4], Seite 655-70.

[120] Villard, E.; Duboscq-Bidot, L.; Charron, P.; Benaiche, A.; Conraads, V.; Sylvius, N. und Komajda, M. (2005): Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene, Eur Heart J (15), Seite 15

[121] Herskowitz, I. (1987): Functional inactivation of genes by dominant negative mutations, Nature (329) [6136], Seite 219-22.

[122] Rayment, I.; Holden, H. M.; Sellers, J. R.; Fananapazir, L. und Epstein, N. D. (1995): Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy, Proc Natl Acad Sci U S A (92) [9], Seite 3864-8.

[123] Geisterfer-Lowrance, A. A.; Christe, M.; Conner, D. A.; Ingwall, J. S.; Schoen, F. J.; Seidman, C. E. und Seidman, J. G. (1996): A mouse model of familial hypertrophic cardiomyopathy, Science (272) [5262], Seite 731-4.

[124] Fatkin, D.; Christe, M. E.; Aristizabal, O.; McConnell, B. K.; Srinivasan, S.; Schoen, F. J.; Seidman, C. E.; Turnbull, D. H. und Seidman, J. G. (1999): Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene, J Clin Invest (103) [1], Seite 147-53.

[125] McConnell, B. K.; Jones, K. A.; Fatkin, D.; Arroyo, L. H.; Lee, R. T.; Aristizabal, O.; Turnbull, D. H.; Georgakopoulos, D.; Kass, D.; Bond, M.; Niimura, H.; Schoen, F. J.; Conner, D.; Fischman, D. A.; Seidman, C. E. und Seidman, J. G. (1999): Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice, J Clin Invest (104) [9], Seite 1235-44.

[126] Karkkainen, S.; Helio, T.; Jaaskelainen, P.; Miettinen, R.; Tuomainen, P.; Ylitalo, K.; Kaartinen, M.; Reissell, E.; Toivonen, L.; Nieminen, M. S.; Kuusisto, J.; Laakso, M. und Peuhkurinen, K. (2004): Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy, Eur J Heart Fail (6) [7], Seite 861-8.

[127] Li, D.; Czernuszewicz, G. Z.; Gonzalez, O.; Tapscott, T.; Karibe, A.; Durand, J. B.; Brugada, R.; Hill, R.; Gregoritch, J. M.; Anderson, J. L.; Quinones, M.; Bachinski, L. L. und Roberts, R. (2001): Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy, Circulation (104) [18], Seite 2188-93.

[128] Stefanelli, C. B.; Rosenthal, A.; Borisov, A. B.; Ensing, G. J. und Russell, M. W. (2004): Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity, Mol Genet Metab (83) [1-2], Seite 188-96.

[129] Hanson, E. L.; Jakobs, P. M.; Keegan, H.; Coates, K.; Bousman, S.; Dienel, N. H.; Litt, M. und Hershberger, R. E. (2002): Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy, J Card Fail (8) [1], Seite 28-32.

[130] Gille, C. und Frömmel, C. (2001): STRAP: editor for STRuctural Alignments of Proteins, Bioinformatics (17) [4], Seite 377-8.

[131] Srikakulam, R. und Winkelmann, D. A. (1999): Myosin II folding is mediated by a molecular chaperonin, J Biol Chem (274) [38], Seite 27265-73.

[132] Schönberger, J. und Seidman, C. E. (2001): Many roads lead to a broken heart: the genetics of dilated cardiomyopathy, Am J Hum Genet (69) [2], Seite 249-60.

[133] Baig, M. K.; Goldman, J. H.; Caforio, A. L.; Coonar, A. S.; Keeling, P. J. und McKenna, W. J. (1998): Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease, J Am Coll Cardiol (31) [1], Seite 195-201.

[134] Poole-Wilson, P. A.; Swedberg, K.; Cleland, J. G.; Di Lenarda, A.; Hanrath, P.; Komajda, M.; Lubsen, J.; Lutiger, B.; Metra, M.; Remme, W. J.; Torp-Pedersen, C.; Scherhag, A. und Skene, A. (2003): Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial, Lancet (362) [9377], Seite 7-13.

[135] (1992): The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions., N Engl J Med (327) [10], Seite 685-91.

[136] Waagstein, F.; Bristow, M. R.; Swedberg, K.; Camerini, F.; Fowler, M. B.; Silver, M. A.; Gilbert, E. M.; Johnson, M. R.; Goss, F. G. und Hjalmarson, A. (1993): Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group, Lancet (342) [8885], Seite 1441-6.

[137] Hosenpud, J. D.; Bennett, L. E.; Keck, B. M.; Boucek, M. M. und Novick, R. J. (2000): The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000, J Heart Lung Transplant (19) [10], Seite 909-31.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
04.07.2007